GreenLight Biosciences Holdings PBC (GRNA)

US39536G1058 - Common Stock

0.2995  0 (-0.03%)

After market: 0.2995 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024
Revenue
YoY % growth
1.747M
-41.79%
1.595M
-8.70%
6.78M
325.08%
7.242M
6.81%
EBITDA
YoY % growth
N/A-102.786M-154.884M
-50.69%
-127.194M
17.88%
EBIT
YoY % growth
-52.284M
-79.04%
-108.558M
-107.63%
-162.96M
-50.11%
-136.374M
16.31%
Operating Margin
-2,992.79%-6,806.14%-2,403.54%-1,883.10%
EPS
YoY % growth
N/AN/AN/A-0.85

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 23 Q3 / 23 Q4 / 23
EPS
Q2Q % growth
-0.27
Revenue
Q2Q % growth
510K
-71.15%
EBITDA
Q2Q % growth
-38.006M
EBIT
Q2Q % growth
-30.906M
40.52%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2022
Q2Q % growth
-0.25 -0.260.012.16%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2023
Q2Q % growth
3.82M
1,386.38%
1.02M2.8M274.51%
Q4 2022
Q2Q % growth
3.023M
628.43%
1.632M1.391M85.23%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-58.24% -7.82% -14.11% -14.11%
Revenue0% 0% 69.05% 69.05%